• Exchange: Continuous
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Bionaturis - Bioorganic Research Serv.

+ Add to Watchlist

BNT:SM

8.250 EUR 1.050 11.29%

As of 11:39:00 ET on 07/11/2014.

Snapshot for Bionaturis - Bioorganic Research Serv. (BNT)

Open: 9.300 Day's Range: 7.550 - 9.640 Volume: 26,308
Previous Close: 9.300 52wk Range: 1.580 - 13.980 1-Yr Rtn: +302.44%

Stock Chart for BNT

No chart data available.
  • BNT:SM 8.250
  • 1D
  • 1M
  • 1Y
9.300
Interactive BNT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BNT

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. IBEX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 38.22
Shares Outstanding (M) 4.63
30 Day Average Volume 38,896
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/26/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BNT

No data available

Company Profile & Key Executives for BNT

Bionaturis produces biopharmaceutical products for the human health and veterinary markets. The Company develops and manufactures treatments for niche diseases, including orphan diseases.

Juan Jose Almagro GarciaChairmanVictor Manuel Infante VinoloChief Executive Officer
Javier GallasteguiManaging DirectorJose Maria LozanoChief Financial Officer
More Company Profile & Key Executives for BNT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil